Hepatitis C and diabetes: the inevitable coincidence?

References

• Naunyn B. Glykosurie und Diabetes durch experimentelle Insulite und Kankheiten der Leber. In: Der Diabetes Mellitus. Naunyn B (Ed). Nothnagel, Vienna, Austria (1906).
   Google Scholar
• Reinberg MH, Lipson M. The association of Laennec’s cirrhosis with diabetes mellitus. Ann. Intern. Med.33(5), 1195–1202 (1950).
   PubMed Web of Science ®Google Scholar
• Kopetz K. The pathogenesis of hepatogenic diabetes mellitus. Klin. Wochenschr.48(21), 1259–1265 (1970).
   PubMedGoogle Scholar
• Cacciatore L, Grazia Giardina M, Cozzolino G et al. Diabetes mellitus and chronic liver disease. Gastroenterology88(5 Pt 1), 1292. Erratum in: Gastroenterology (1985)89, 1219 (1985).
   PubMedGoogle Scholar
• Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J. Hepatol.21(6), 1135–1139 (1994).
   PubMed Web of Science ®Google Scholar
• Giusti G, Pasquale G, Galante D et al. Clinical and histological aspects of chronic HCV infection and cirrhosis. Hepatogastroenterology40(4), 365–369 (1993).
   PubMedGoogle Scholar
• Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin. Liver Dis.15(1), 70–81 (1995).
   PubMed Web of Science ®Google Scholar
• Fischer HP, Willsch E, Bierhoff E, Pfeifer U. Histopathologic findings in chronic hepatitis C. J. Hepatol.24(2 Suppl.), 35–42 (1996).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G. Hepatitis C and steatosis: a reappraisal. J. Viral Hepat.13(2), 73–80 (2006).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Adinolfi LE, Loria P et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology126(2), 586–597 (2004).
   PubMed Web of Science ®Google Scholar
• Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int. J. Obes. Relat. Metab. Disord.19(Suppl. 3), S27–S36 (1995).
   PubMedGoogle Scholar
• Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine (Baltimore)75(6), 327–333 (1996).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet366(9491), 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest.115(5), 1343–1351 (2005)
   PubMed Web of Science ®Google Scholar
• Lonardo A, Lombardini S, Scaglioni F et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J. Hepatol.44(1), 190–196 (2006).
   PubMed Web of Science ®Google Scholar
• Minehira K, Young SG, Villanueva CJ et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res.49(9), 2038–2044 (2008).
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Machicao F, Machann J et al. The DGAT2 gene is a candidate for dissociation between fatty liver and insulin resistance in humans. Clin. Sci. (Lond)116(6), 531–517 (2008).
   Web of Science ®Google Scholar
• Schonfeld G, Yue P, Lin X, Chen Z. Fatty liver and insulin resistance: not always linked. Trans. Am. Clin. Climatol. Assoc.119, 217–224 (2008).
   PubMedGoogle Scholar
• Mirandola S, Realdon S, Iqbal J et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology130(6), 1661–1669 (2006).
   PubMed Web of Science ®Google Scholar
• Zampino R, Ingrosso D, Durante-Mangoni E et al. Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J. Viral Hepat.15(10), 740–746 (2008).
   PubMed Web of Science ®Google Scholar
• Hui JM, Sud A, Farrell GC et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology125(6), 1695–1704 (2003).
   PubMed Web of Science ®Google Scholar
• Ratziu V, Munteanu M, Charlotte F, Bonyhay L, Poynard T. LIDO Study Group. Fibrogenic impact of high serum glucose in chronic hepatitis C. J. Hepatol.39(6), 1049–1055 (2003).
   PubMed Web of Science ®Google Scholar
• Sud A, Hui JM, Farrell GC et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology39(5), 1239–1247 (2004).
   PubMed Web of Science ®Google Scholar
• D’Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am. J. Gastroenterol.100(7), 1509–1515 (2005).
   PubMed Web of Science ®Google Scholar
• Muzzi A, Leandro G, Rubbia-Brandt L et al. Swiss Hepatitis C Cohort Study. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J. Hepatol.42(1), 41–46 (2005).
   PubMed Web of Science ®Google Scholar
• Fartoux L, Poujol-Robert A, Guechot J et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut54(7), 1003–1008 (2005).
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Marchesini G, Gentilcore E et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology44(6), 1648–1655 (2006).
   PubMed Web of Science ®Google Scholar
• Taura N, Ichikawa T, Hamasaki K et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am. J. Gastronterol.101(12), 2752–2759 (2006).
   PubMed Web of Science ®Google Scholar
• Masarone M, La Mura V, Bruno S et al. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease. J. Viral Hepat.14(10), 714–720 (2007).
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, Bugianesi E, Bouserhal T et al. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut56(9), 1296–1301 (2007).
   PubMed Web of Science ®Google Scholar
• Petta S, Cammà C, Marco VD et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am. J. Gastroenterol.103(5), 1136–1144 (2008).
   PubMed Web of Science ®Google Scholar
• Moucari R, Asselah T, Cazals-Hatem D et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology134(2), 416–423 (2008).
   PubMed Web of Science ®Google Scholar
• Cua IH, Hui JM, Kench JG, George J. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology48(3), 723–731 (2008).
   PubMed Web of Science ®Google Scholar
• Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of Type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin. Proc.75(4), 355–359 (2000).
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Emoto M, Fujiwara S et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese Type 2 diabetic patients. Diabetes Care26(8), 2426–2432 (2003).
   PubMed Web of Science ®Google Scholar
• Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Hepatitis C virus infection and the development of Type 2 diabetes in a community-based longitudinal study. Am. J. Epidemiol.166(2), 196–203 (2007).
   PubMed Web of Science ®Google Scholar
• Mehta SH, Brancati FL, Strathdee SA et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology38(1), 50–56 (2003).
   PubMed Web of Science ®Google Scholar
• Lecube A, Hernandez C, Genesca J et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care27(11), 1171–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signalling in patients with HCV: a mechanism for increased prevalence of Type 2 diabetes. Hepatology38(6), 1384–1392 (2003).
   PubMed Web of Science ®Google Scholar
• Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology47(6), 2127–2133 (2008).
   PubMed Web of Science ®Google Scholar
• Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology122(2), 366–375 (2002).
   PubMed Web of Science ®Google Scholar
• Tardif KD, Mori K, Siddiqui A. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol.76(15), 7453–7459 (2002).
   PubMed Web of Science ®Google Scholar
• Thoren F, Romero A, Lindh M, Dahlgren C, Hellstrand K. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J. Leukoc. Biol.76(6), 1180–1186 (2004).
   PubMed Web of Science ®Google Scholar
• Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κ B. Proc. Natl Acad. Sci. USA98(17), 9599–9604 (2001).
   PubMed Web of Science ®Google Scholar
• Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O. Induction of highmolecular-weight (HMW) tumor necrosis factor (TNF) α by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-κaB-dependent activation. Cell Signal.19(2), 301–311 (2007).
   PubMed Web of Science ®Google Scholar
• Knobler H, Schattner A. TNF-α, chronic hepatitis C and diabetes: a novel triad. QJM98(1), 1–6 (2005).
   PubMed Web of Science ®Google Scholar
• Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology126(3), 840–848 (2004).
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Moriishi K, Moriya K et al. Involvement of the PA28γ-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J. Virol.81(4), 1727–1735 (2007).
   PubMed Web of Science ®Google Scholar
• Knobler H, Zhornicky T, Sandler A et al. Tumor necrosis factor-α-Induced insulin resistance may mediate the hepatitis C virus–diabetes association. Am. J. Gastroenterol.98(12), 2751–2756 (2003).
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling. Am. J. Pathol.165(5), 1499–1508 (2004).
   PubMed Web of Science ®Google Scholar
• Pazienza V, Clément S, Pugnale P et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology45(5), 1164–1171 (2007).
   PubMed Web of Science ®Google Scholar
• Banerjee S, Saito K, Ait-Goughoulte M et al. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream Akt/protein kinase B signaling pathway for insulin resistance. J. Virol.82(6), 2606–2612 (2008).
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Duong FH, Christen V et al. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J. Hepatol.49(3), 429–440 (2008).
   PubMed Web of Science ®Google Scholar
• Asselah T, Bièche I, Laurendeau I et al. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology129(6), 2064–2075 (2005).
   PubMed Web of Science ®Google Scholar
• Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology29(2), 328–333 (1999).
   PubMed Web of Science ®Google Scholar
• Yoneda M, Saito S, Ikeda T et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J. Viral Hepat.14(9), 600–607 (2007).
   PubMed Web of Science ®Google Scholar
• Romero-Gómez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology128(3), 636–641 (2005).
   PubMed Web of Science ®Google Scholar
• Liu CJ, Chen PJ, Jeng YM et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J. Hepatol.43(2), 235–242 (2005).
   PubMed Web of Science ®Google Scholar
• Siagris D, Vafiadis G, Michalaki M et al. Serum adiponectin in chronic hepatitis C and B. J. Viral Hepat.14(8), 577–583 (2007).
   PubMed Web of Science ®Google Scholar
• Zografos TA, Liaskos C, Rigopoulou EI et al. Adiponectin: a new independent predictor of liver steatosis and response to IFN-a treatment in chronic hepatitis C. Am. J. Gastroenterol.103(3), 605–614 (2008).
   PubMed Web of Science ®Google Scholar
• Cua IH, Hui JM, Bandara P et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology46(1), 66–73 (2007).
   PubMed Web of Science ®Google Scholar
• Alter MJ. Epidemiology of hepatitis C virus infection. World J. Gastroenterol.13(17), 2436–2441 (2007).
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Wasley A, Simard EP et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med.144(10), 705–714 (2006).
   PubMed Web of Science ®Google Scholar
• Law MG, Dore GJ, Bath N et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int. J. Epidemiol.32(5), 717–724 (2003).
   PubMed Web of Science ®Google Scholar
• Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J. Med. Virol.65(4), 688–693 (2001).
   PubMed Web of Science ®Google Scholar
• Sun CA, Chen HC, Lu SN et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J. Med. Virol.65(1), 30–34 (2001).
   PubMed Web of Science ®Google Scholar
• Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection30(1), 7–12 (2002).
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Stroffolini T, Mele A et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J. Med. Virol.75(4), 522–527 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang M, Sun XD, Mark SD et al. Hepatitis C virus infection, Linxian, China. Emerg. Infect. Dis.11(1), 17–21 (2005).
   PubMed Web of Science ®Google Scholar
• Di Stefano R, Stroffolini T, Ferraro D et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J. Med. Virol.67(3), 339–344 (2002).
   PubMed Web of Science ®Google Scholar
• Maio G, d’Argenio P, Stroffolini T et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J. Hepatol.33(1), 116–120 (2000).
   PubMed Web of Science ®Google Scholar
• Okayama A, Stuver SO, Tabor E et al. Incident hepatitis C virus infection in a community-based population in Japan. J. Viral Hepat.9(1), 43–51 (2002).
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz F, Habib M, Mohamed MK et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology32(1), 111–115 (2000).
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care27(5), 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care29(6), 1263–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation.106(25), 3143–3421 (2002).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation112(6), 2735–2752 (2005).
   PubMed Web of Science ®Google Scholar
• Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care28(11), 2745–2749 (2005).
   PubMed Web of Science ®Google Scholar
• Miccoli R, Bianchi C, Odoguardi L et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis.15(4), 250–254 (2005).
   PubMed Web of Science ®Google Scholar
• Athyros VG, Bouloukos VI, Pehlivanidis AN et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes. Metab.7(4), 397–405 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrannini E. Metabolic syndrome: a solution in search of a problem. J. Clin. Endocrinol. Metab.92(2), 396–398 (2007).
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care30(1), 8–13 (2007).
   PubMed Web of Science ®Google Scholar
• Weinman SA, Belalcazar LM. Hepatitis C: a metabolic liver disease. Gastroenterology126(3), 917–919 (2004).
   PubMed Web of Science ®Google Scholar
• Cortez-Pinto H. Concluding remarks: metabolic syndrome, liver and HCV. Aliment. Pharmacol. Ther.22(Suppl. 2), 83–85 (2005).
   PubMed Web of Science ®Google Scholar
• Koike K. Hepatitis C as a metabolic disease: implication for the pathogenesis of NASH. Hepatol. Res.33(2), 145–150 (2005).
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA287(3), 356–359 (2002).
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Contos MJ, Sterling RK et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am. J. Gastroenterol.98(9), 2064–2071 (2003).
   PubMed Web of Science ®Google Scholar
• Shaheen M, Echeverry D, Oblad MG et al. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res. Clin. Pract.75(3), 320–326 (2007).
   PubMed Web of Science ®Google Scholar
• Hanouneh IA, Feldstein AE, Lopez R et al. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin. Gastroenterol. Hepatol.6(5), 584–589 (2008).
   PubMed Web of Science ®Google Scholar
• Persico M, Capasso M, Persico E et al. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology46(4), 1009–1015 (2007).
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, Bugianesi E, Bouserhal T et al. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut56(9), 1296–1301 (2007).
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J. Hepatol.46(6), 1126–1132 (2007).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Ballestri S, Adinolfi LE et al. HCV infected patients are “spared” from the metabolic syndrome but not from insulin resistance. A comparative study of NAFLD and HCV-related steatosis. Can. J. Gastro.23 (2009) (In Press).
   PubMed Web of Science ®Google Scholar
• Tsochatzis E, Papatheodoridis GV, Manesis EK et al. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther.27(1), 80–89 (2008).
   PubMed Web of Science ®Google Scholar
• Chen W, Wong T, OmlinsonG, Murray Krahn M, Heathcote EJ. Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic. J. Hepatol.49(5), 711–717 (2008).
   PubMed Web of Science ®Google Scholar
• Dai CY, Chuang WL, Ho CK et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J. Hepatol.49(1), 9–16 (2008).
   PubMed Web of Science ®Google Scholar
• Poynard T, Cacoub P, Ratziu V et al. Fatigue in patients with chronic hepatitis C. J. Viral Hepat.9(4), 295–303 (2002).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Loria P. The hepatitis C virus-associated dysmetabolic syndrome. Hepatology48(3), 1018–1019 (2008).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Loria P, Carulli N. Dysmetabolic changes associated with HCV: a distinct syndrome? Intern. Emerg. Med.3(2), 99–108 (2008).
   PubMed Web of Science ®Google Scholar
• Sheikh SM. The hepatitis C virus-associated dysmetabolic syndrome. Reply. Hepatology48(3), 9 (2008).
   Google Scholar
• Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care19(9), 998–1000 (1996).
   PubMed Web of Science ®Google Scholar
• Sangiorgio L, Attardo T, Gangemi R et al. Increased frequency of HCV and HBV infection in Type 2 diabetic patients. Diabetes Res. Clin. Pract.48(2), 147–151 (2000).
   PubMed Web of Science ®Google Scholar
• Okan V, Araz M, Aktaran S et al. Increased frequency of HCV but not HBV infection in Type 2 diabetic patients in Turkey. Int. J. Clin. Pract.56(3), 175–177 (2002).
   PubMed Web of Science ®Google Scholar
• Arao M, Murase K, Kusakabe A et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J. Gastroenterol.38(4), 355–360 (2003).
   PubMed Web of Science ®Google Scholar
• Chen HF, Li CY, Chen P, See TT, Lee HY. Seroprevalence of hepatitis B and C in Type 2 diabetic patients. J. Chin. Med. Assoc.69(4), 146–152 (2006).
   PubMedGoogle Scholar
• Parolin MB, Réa R, Vargas RM et al. Prevalence of hepatitis C infection in patients with Type 2 diabetes mellitus. Arq. Gastroenterol.43, 71–72 (2006).
   PubMedGoogle Scholar
• Huang JF, Dai CY, Hwang SJ et al. Hepatitis C viremia increases the association with Type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am. J. Gastroenterol.102(6), 1237–1243 (2007).
   PubMed Web of Science ®Google Scholar
• Picerno I, Di Pietro A, Spataro P et al. Is diabetes mellitus a risk factor for HCV infection? Ann. Ig.14(6), 473–477 (2002)
   PubMedGoogle Scholar
• Costa LM, Mussi AD, Brianeze MR, Souto FJ. Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Braz. J. Infect. Dis.12(1), 24–26 (2008).
   PubMed Web of Science ®Google Scholar
• Grimbert S, Valensi P, Levy-Marchal C et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A caseþcontrol study. Gastroenterol. Clin. Biol.20(6–7), 544–548 (1996).
   PubMedGoogle Scholar
• El-Zayadi AR, Selim OE, Hamdy H et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop. Gastroenterol.19(4), 141–144 (1998).
   PubMedGoogle Scholar
• Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology30(4), 1059–1063 (1999).
   PubMed Web of Science ®Google Scholar
• Boschi-Pinto C, Stuver S, Okayama A et al. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J. Infect. Dis.181(1), 35–41 (2000).
   PubMed Web of Science ®Google Scholar
• Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J. Hepatol.32(2), 209–217 (2000).
   PubMed Web of Science ®Google Scholar
• Bigam DL, Pennington JJ, Carpentier A et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology32(1), 87–90 (2000).
   PubMed Web of Science ®Google Scholar
• Qureshi H, Ahsan T, Mujeeb SA et al. Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J. Pak. Med. Assoc.52(7), 280–283 (2002).
   PubMedGoogle Scholar
• Akbar DH, Siddique AM, Ahmed MM. Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med. Princ. Pract.11(2), 82–85 (2002).
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. A case–control study. Am. J. Gastroenterol.98(2), 438–441 (2003).
   PubMed Web of Science ®Google Scholar
• Howard AA, Klein RS, Schoenbaum EE. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin. Infect. Dis.36(10), 1318–1323 (2003).
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferri C, Fallahi P et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford)43(2), 238–224 (2004).
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferri C, Fallahi P et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care28, 2548–2550 (2005).
   PubMed Web of Science ®Google Scholar
• Papatheodoridis GV, Chrysanthos N, Savvas S et al. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J. Viral Hepat.13(5), 303–310 (2006).
   PubMed Web of Science ®Google Scholar
• Butt AA, Evans R, Skanderson M, Shakil AO. Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis. J. Hepatol.44(3), 864–868 (2006).
   PubMed Web of Science ®Google Scholar
• Marzouk D, Sass J, Bakr I et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut56(8), 1105–1110 (2007).
   PubMed Web of Science ®Google Scholar
• Imazeki F, Yokosuka O, Fukai K et al. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus infected and hepatitis C virus-cleared patients. Liver Int.28(3), 355–362 (2008).
   PubMed Web of Science ®Google Scholar
• White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J. Hepatol.49(5), 831–844 (2008).
   PubMed Web of Science ®Google Scholar
• Mehta SH, Brancati FL, Sulkowski MS et al. Prevalence of Type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann. Intern. Med.133(8), 592–599 (2000).
   PubMed Web of Science ®Google Scholar
• Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Community-based study of hepatitis C virus infection and Type 2 diabetes: an association affected by age and hepatitis severity status. Am. J. Epidemiol.158(12), 1154–1160 (2003).
   PubMed Web of Science ®Google Scholar
• Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J. Clin. Gastroenterol.26(1), 30–33 (1998).
   PubMed Web of Science ®Google Scholar
• Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation72(6), 1066–1072 (2001).
   PubMed Web of Science ®Google Scholar
• Khalili M, Lim JW, Bass N et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl.10(3), 349–355 (2004).
   PubMed Web of Science ®Google Scholar
• Delgado-Borrego A, Casson D, Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation77(5), 703–710 (2004).
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Lampertico P, Lunghi G et al. Review article: hepatitis C virus infection and Type-2 diabetes mellitus in renal diseases and transplantation. Aliment. Pharmacol. Ther.21(6), 623–632 (2005).
   PubMed Web of Science ®Google Scholar
• Butt AA, Fultz SL, Kwoh CK et al. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology40(1), 115–119 (2004).
   PubMed Web of Science ®Google Scholar
• Ledergerber B, Furrer H, Rickenbach M et al. Factors associated with the incidence of Type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin. Infect. Dis.45(1), 111–119 (2007).
   PubMed Web of Science ®Google Scholar
• Stapleton JT, Bennett K, Bosch RJ, Polgreen PM, Swindells S. Effect of antiretroviral therapy and hepatitis C co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy. HIV Clin. Trials8(6), 429–436 (2007).
   PubMed Web of Science ®Google Scholar
• Jain MK, Aragaki C, Fischbach L et al. Hepatitis C is associated with Type 2 diabetes mellitus in HIV-infected persons without traditional risk factors. HIV Med.8(8), 491–497 (2007).
   PubMed Web of Science ®Google Scholar
• Brar I, Shuter J, Thomas A, Daniels E, Absalon J. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J. Acq. Immun. Def. Synd.45(1), 66–71 (2007).
   PubMed Web of Science ®Google Scholar
• Adinolfi LE, Gambardella M, Andreana A et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology33(6), 1358–1364 (2001).
   PubMed Web of Science ®Google Scholar
• Asselah T, Boyer N, Guimont MC et al. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut52(11), 1638–1643 (2003).
   PubMed Web of Science ®Google Scholar
• Rubbia-Brandt L, Fabris P, Paganin S et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut53(3), 406–412 (2004).
   PubMed Web of Science ®Google Scholar
• Patton HM, Patel K, Behling C et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J. Hepatol.40(3), 484–490 (2004).
   PubMed Web of Science ®Google Scholar
• Bianchi G, Marchesini G, Zoli M et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatology20(1 Pt 1), 119–125 (1994).
   PubMed Web of Science ®Google Scholar
• Nishida T, Tsuji S, Tsujii M et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am. J. Gastroenterol.101(1), 70–75 (2006).
   PubMed Web of Science ®Google Scholar
• Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am. J. Gastroenterol.101(7), 1490–1496 (2006).
   PubMed Web of Science ®Google Scholar
• Walsh MJ, Jonsson JR, Richardson MM et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut55(4), 529–535 (2006).
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Ide T, Taniguchi E et al. Clearance of HCV improves insulin resistance, β-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am. J. Gastroenterol.102(3), 570–576 (2007).
   PubMed Web of Science ®Google Scholar
• Tanaka H, Shiota G, Kawasaki H. Changes in glucose tolerance after interferon-α therapy in patients with chronic hepatitis C. J. Med.28(5–6), 335–346 (1997).
   PubMedGoogle Scholar
• Simó R, Lecube A, Genescà J, Esteban JI, Hernández C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care29(11), 2462–2466 (2006).
   PubMed Web of Science ®Google Scholar
• Giordanino C, Bugianesi E, Smedile A et al. Incidence of Type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am. J. Gastroenterol.103(10), 2481–2487 (2008).
   PubMed Web of Science ®Google Scholar
• Arase Y, Suzuki F, Suzuki Y, Akuta N et al. Sustained virological response reduces incidence of onset of Type 2 diabetes in chronic hepatitis C. Hepatology49(3), 739–744 (2009).
   PubMed Web of Science ®Google Scholar
• Kwon SY, Kim SS, Kwon OS et al. Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus. Diabet. Med.22(11), 1530–1535 (2005).
   PubMed Web of Science ®Google Scholar
• Hickman IJ, Clouston AD, Macdonald GA et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut51(1), 89–94 (2002).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Carulli N, Loria P. HCV and diabetes. A two-question-based reappraisal. Dig. Liver Dis.39(8), 753–761 (2007).
   PubMedGoogle Scholar
• Mangia A, Schiavone G, Lezzi G et al. HCV and diabetes mellitus: evidence for a negative association. Am. J. Gastroenterol.93(12), 2363–2367 (1998).
   PubMed Web of Science ®Google Scholar